GALNS and mucopolysaccharidosis type 4A: Previously, we reported a CRISPR/nCas9-based GT strategy for inserting an expression cassette carrying the GALNS cDNA into the AAVS1 locus in human MPS IVA fibroblasts using non-viral vectors [37,38].